Abstract
It has been previously shown that amino acid polymorphisms in reovirus proteins μ2 and λ1 are associated with differing levels of interferon induction. In the present study, viruses carrying these polymorphisms in either or both proteins, were further studied. The two viral determinants exert a synergistic effect on the control of β-interferon induction at the protein and mRNA level, with a concomitant increase in RIG-I. In contrast, levels of phospho-Stat1 and interferon-stimulated genes are increased in singly substituted viruses but with no further increase when both substitutions were present. This suggests that the viral determinants are acting during initial events of viral recognition. Accordingly, difference between viruses was reduced when infection was performed with partially uncoated virions (ISVPs) and transfection of RNA recovered from early-infected cells recapitulates the differences between viruses harboring the different polymorphisms. Altogether, the data are consistent with a redundant or complementary role of μ2 and λ1, affecting either early disassembly or the nature of the viral RNA in the incoming viral particle. Proteins involved in viral RNA synthesis are thus involved in this likely critical aspect of the ability of different reovirus variants to infect various cell types, and to discriminate between parental and transformed/cancer cells.
Funder
National Sciences and Engineering Research Council of Canada
Subject
Virology,Infectious Diseases
Reference59 articles.
1. Dermody, T.S., Parker, J.S.L., and Sherry, B.L. (2013). Field’s Virology, Lippincott, Williams and Wilkins. Chapter 44 (Orthoreoviruses).
2. Genetic manipulation of reovirus--a model for modification of disease;N. Engl. J. Med.,1972
3. Studies of reovirus pathogenesis reveal potential sites for antiviral intervention;Adv. Exp. Med. Biol.,1992
4. Pathogenesis of viral infections. Basic concepts derived from the reovirus model;N. Engl. J. Med.,1985
5. The oncolytic virus, pelareorep, as a novel anticancer agent: A review;Investig. N. Drugs,2015